methadone has been researched along with Cognition Disorders in 33 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate the impaired attention selection (Stroop interference effect) and general performance [reaction times (RTs)] on the Stroop task among methadone maintenance treatment (MMT) patients with obsessive compulsive disorder (OCD), pathological gambling (PG), both PG/OCD or none, and the influence if having ADHD." | 7.80 | Stroop task among patients with obsessive-compulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT). ( Adelson, M; Peles, E; Sason, A; Schreiber, S; Weinstein, A, 2014) |
"To evaluate the impaired attention selection (Stroop interference effect) and general performance [reaction times (RTs)] on the Stroop task among methadone maintenance treatment (MMT) patients with obsessive compulsive disorder (OCD), pathological gambling (PG), both PG/OCD or none, and the influence if having ADHD." | 3.80 | Stroop task among patients with obsessive-compulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT). ( Adelson, M; Peles, E; Sason, A; Schreiber, S; Weinstein, A, 2014) |
"Prior research has demonstrated neuropsychological (NP) impairment in persons with histories of injection drug use (IDU), hepatitis C virus (HCV) infection, and methadone maintenance treatment (MMT), individually, but little is known about the NP effects of these three risk factors in combination." | 3.80 | Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment. ( Duarte, N; Franklin, DR; Grant, I; Gupta, S; Hampton Atkinson, J; Heaton, RK; Iudicello, JE; Jin, H; Knight, A; Letendre, S; Li, J; Riggs, PK; Shi, C; Wu, Z; Yu, X, 2014) |
" A 61-year-old man presented with severe cognitive dysfunction after long-term methadone treatment for intercostal neuralgia and was diagnosed with GH insufficiency by GH releasing hormone-arginine testing." | 3.80 | Recombinant human growth hormone improves cognitive capacity in a pain patient exposed to chronic opioids. ( Gordh, T; Grönbladh, A; Nyberg, F; Ortiz-Nieto, F; Raininko, R; Rhodin, A; Skottheim, B; von Ehren, M, 2014) |
" In the present paper, we compared the decision-making ability using the Iowa gambling task of methadone- and buprenorphine-maintained individuals to non opiate-dependent drug-free controls." | 3.73 | Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. ( Bini, V; Diana, M; Fais, R; Falconieri, D; Messina, M; Pirastu, R; Spiga, S, 2006) |
"An accumulating body of research suggests that former heroin abusers in methadone maintenance therapy (MMT) exhibit deficits in cognitive function." | 3.73 | Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. ( Cohen, LJ; Eisenberg, D; Galynker, II; London, ED; Prosser, J; Steinfeld, M, 2006) |
" Cognitive testing took place at 2 time points: study weeks 4 through 5 to assess baseline performance and 10 to 13 weeks later to assess performance during stable dosing (300 mg topiramate or placebo)." | 2.80 | Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence. ( Bigelow, GE; Johnson, MW; Mintzer, MZ; Rass, O; Strain, EC; Umbricht, A, 2015) |
"5mg) may be an effective mechanism for safely dosing this medication in persons with higher levels of physical dependence." | 2.73 | Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. ( Bigelow, GE; Rosado, J; Strain, EC; Walsh, SL, 2007) |
"Severity of opioid dependence, and performance on two successive runs of the Wisconsin Card Sorting Test (WCST), were assessed in 39 right-handed male and female methadone patients who had been randomly assigned to either a recently dosed (n=21) or 24 hr abstinent (n=18) condition." | 2.71 | Neuropsychological correlates of opioid dependence and withdrawal. ( Lyvers, M; Yakimoff, M, 2003) |
"This hypothesis predicts that drug abusers should excel on tests of knowledge that is related to their lifestyle." | 2.69 | Forms of knowledge, cognitive impairment and drug abuse: a demonstration. ( Beatty, WW; Borrell, GK, 2000) |
"Methadone has been used as a pharmacotherapy for the treatment of opiate dependence since the mid-1960s." | 2.49 | Methadone maintenance treatment and cognitive function: a systematic review. ( Russell, BR; Wang, GY; Wouldes, TA, 2013) |
"Methadone maintenance treatment (MMT) has been used to treat opiate dependence since the mid-1960s." | 1.40 | Neuropsychological performance of methadone-maintained opiate users. ( Jensen, M; Kydd, R; Russell, BR; Wang, GY; Wouldes, TA, 2014) |
"Thirty HIV-negative substance users were individually matched to 30 HIV-positive substance users on relevant medical and demographic factors, including reading level and methadone therapy status." | 1.39 | Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study. ( Byrd, DA; Elliott, K; Lighty, Q; Mindt, MR; Mintz, L; Morgello, S; Robinson-Papp, J, 2013) |
"Buprenorphine-treated patients performed statistically significantly better in a simple reaction time test than methadone-treated ones." | 1.38 | Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study. ( Alho, H; Fabritius, C; Kalska, H; Rapeli, P, 2012) |
"Methadone-treated patients, as a group, had significantly slower simple reaction time (RT) compared to buprenorphine/naloxone-treated patients." | 1.34 | Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. ( Alho, H; Fabritius, C; Kalska, H; Rapeli, P; Salaspuro, M; Wahlbeck, K, 2007) |
"A life-time diagnosis of alcohol dependence and the number of non-fatal heroin overdoses were independent significant predictors of poorer cognitive performance." | 1.31 | Cognitive impairment among methadone maintenance patients. ( Darke, S; McDonald, S; Sims, J; Wickes, W, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.06) | 18.7374 |
1990's | 5 (15.15) | 18.2507 |
2000's | 16 (48.48) | 29.6817 |
2010's | 10 (30.30) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byrd, DA | 1 |
Robinson-Papp, J | 1 |
Mindt, MR | 1 |
Mintz, L | 1 |
Elliott, K | 1 |
Lighty, Q | 1 |
Morgello, S | 1 |
Wang, GY | 2 |
Wouldes, TA | 2 |
Russell, BR | 2 |
Peles, E | 2 |
Weinstein, A | 1 |
Sason, A | 1 |
Adelson, M | 2 |
Schreiber, S | 2 |
Gupta, S | 1 |
Iudicello, JE | 1 |
Shi, C | 1 |
Letendre, S | 1 |
Knight, A | 1 |
Li, J | 1 |
Riggs, PK | 1 |
Franklin, DR | 1 |
Duarte, N | 1 |
Jin, H | 1 |
Hampton Atkinson, J | 1 |
Yu, X | 1 |
Wu, Z | 1 |
Grant, I | 1 |
Heaton, RK | 1 |
Rhodin, A | 1 |
von Ehren, M | 1 |
Skottheim, B | 1 |
Grönbladh, A | 1 |
Ortiz-Nieto, F | 1 |
Raininko, R | 1 |
Gordh, T | 1 |
Nyberg, F | 1 |
Kydd, R | 1 |
Jensen, M | 1 |
Rass, O | 1 |
Umbricht, A | 1 |
Bigelow, GE | 2 |
Strain, EC | 2 |
Johnson, MW | 1 |
Mintzer, MZ | 2 |
Linzy, S | 1 |
Domani, Y | 1 |
Loeber, S | 1 |
Kniest, A | 1 |
Diehl, A | 1 |
Mann, K | 1 |
Croissant, B | 1 |
Shprecher, DR | 1 |
Flanigan, KM | 1 |
Smith, AG | 1 |
Smith, SM | 1 |
Schenkenberg, T | 1 |
Steffens, J | 1 |
Rapeli, P | 2 |
Fabritius, C | 2 |
Kalska, H | 2 |
Alho, H | 2 |
McDonald, S | 2 |
Darke, S | 2 |
Kaye, S | 1 |
Torok, M | 1 |
Margolin, A | 1 |
Avants, SK | 1 |
Warburton, LA | 1 |
Hawkins, KA | 1 |
Lyvers, M | 1 |
Yakimoff, M | 1 |
Arciniegas, DB | 1 |
Frey, KL | 1 |
Anderson, CA | 1 |
Brousseau, KM | 1 |
Harris, SN | 1 |
Verdejo, A | 1 |
Toribio, I | 1 |
Orozco, C | 1 |
Puente, KL | 1 |
Pérez-García, M | 1 |
Pirastu, R | 1 |
Fais, R | 1 |
Messina, M | 1 |
Bini, V | 1 |
Spiga, S | 1 |
Falconieri, D | 1 |
Diana, M | 1 |
Prosser, J | 1 |
Cohen, LJ | 1 |
Steinfeld, M | 1 |
Eisenberg, D | 1 |
London, ED | 1 |
Galynker, II | 1 |
Brooks, DJ | 1 |
Vosburg, SK | 1 |
Evans, SM | 1 |
Levin, FR | 1 |
Howe, EG | 1 |
Rosado, J | 1 |
Walsh, SL | 1 |
Salaspuro, M | 1 |
Wahlbeck, K | 1 |
Ege, PP | 1 |
Boccellari, AA | 1 |
Chambers, DB | 1 |
Dilley, JW | 1 |
Shore, MD | 1 |
Tauber, MA | 1 |
Moss, AR | 1 |
Osmond, DH | 1 |
Handelsman, L | 1 |
Song, IS | 1 |
Losonczy, M | 1 |
Park, S | 1 |
Jacobson, J | 1 |
Wiener, J | 1 |
Aronson, M | 1 |
Sternon, J | 1 |
King, VL | 1 |
Brooner, RK | 1 |
Kidorf, MS | 1 |
Stoller, KB | 1 |
Mirsky, AF | 1 |
Beatty, WW | 1 |
Borrell, GK | 1 |
Sims, J | 1 |
Wickes, W | 1 |
Stitzer, ML | 1 |
Davis, PE | 1 |
Liddiard, H | 1 |
McMillan, TM | 1 |
Herl, D | 1 |
Silberstein, CH | 1 |
McKegney, FP | 1 |
O'Dowd, MA | 1 |
Selwyn, PA | 1 |
Schoenbaum, E | 1 |
Drucker, E | 1 |
Feiner, C | 1 |
Cox, CP | 1 |
Friedland, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Amantadine for Neuroenhancement in Acute Patients Study - A Prospective Pilot Proof of Concept Phase IIb Study in Intensive and Intermediate Care Unit Patients[NCT05479032] | Phase 2 | 50 participants (Anticipated) | Interventional | 2022-09-30 | Not yet recruiting | ||
Treatment of Adult ADHD in Methadone Patients[NCT00061087] | Phase 2/Phase 3 | 115 participants (Actual) | Interventional | 1998-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for methadone and Cognition Disorders
Article | Year |
---|---|
Methadone maintenance treatment and cognitive function: a systematic review.
Topics: Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Humans; Methadone; Opiate Substitu | 2013 |
5 trials available for methadone and Cognition Disorders
Article | Year |
---|---|
Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence.
Topics: Adult; Cocaine-Related Disorders; Cognition Disorders; Diagnosis, Dual (Psychiatry); Double-Blind Me | 2015 |
Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cognition Disorders; Dose-Response Relationship, Drug; Fem | 2008 |
Neuropsychological correlates of opioid dependence and withdrawal.
Topics: Adolescent; Adult; Cognition Disorders; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Neu | 2003 |
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
Topics: Administration, Sublingual; Adult; Buprenorphine; Cognition Disorders; Double-Blind Method; Drug Com | 2007 |
Forms of knowledge, cognitive impairment and drug abuse: a demonstration.
Topics: Adult; Cocaine-Related Disorders; Cognition Disorders; Female; Humans; Knowledge; Male; Methadone; M | 2000 |
27 other studies available for methadone and Cognition Disorders
Article | Year |
---|---|
Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.
Topics: Adult; Cognition Disorders; Cohort Studies; Female; HIV Infections; Humans; Male; Methadone; Middle | 2013 |
Stroop task among patients with obsessive-compulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT).
Topics: Adult; Age Factors; Aged; Analgesics, Opioid; Analysis of Variance; Attention Deficit Disorder with | 2014 |
Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.
Topics: Adult; Asian People; Cognition Disorders; Female; Hepatitis C; Humans; Male; Methadone; Neuropsychol | 2014 |
Recombinant human growth hormone improves cognitive capacity in a pain patient exposed to chronic opioids.
Topics: Apoptosis; Arginine; Aspartic Acid; Cognition Disorders; Creatine; Growth Hormone; Growth Hormone-Re | 2014 |
Neuropsychological performance of methadone-maintained opiate users.
Topics: Adolescent; Adult; Attention; Case-Control Studies; Cognition Disorders; Drug Users; Executive Funct | 2014 |
Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Central Nervous System Stimul | 2015 |
Clinical and diagnostic features of delayed hypoxic leukoencephalopathy.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Brain; Cocaine; Cognition Disorders; Depressive Disorder | 2008 |
Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.
Topics: Adult; Analgesics, Opioid; Attention; Buprenorphine; Cognition Disorders; Drug Therapy, Combination; | 2012 |
Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users.
Topics: Adult; Analysis of Variance; Buprenorphine; Case-Control Studies; Cognition Disorders; Emotions; Fem | 2013 |
Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users.
Topics: Adult; CD4 Lymphocyte Count; Cognition Disorders; Educational Status; Female; HIV Infections; HIV-1; | 2002 |
Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy.
Topics: Adult; Amantadine; Brain; Brain Injuries; Cognition Disorders; Demyelinating Diseases; Diazepam; Dop | 2004 |
Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
Topics: Adult; Alcoholism; Cocaine-Related Disorders; Cognition Disorders; Female; Heroin Dependence; Humans | 2005 |
Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies.
Topics: Adult; Buprenorphine; Cognition Disorders; Decision Making; Female; Gambling; Humans; Male; Methadon | 2006 |
Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment.
Topics: Adult; Cognition Disorders; Demography; Female; Heroin Dependence; Humans; Male; Mass Screening; Met | 2006 |
Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders; Cognition Disorders | 2006 |
Do we undervalue feelings in patients who are cognitively impaired?
Topics: Aggression; Alzheimer Disease; Analgesics, Opioid; Anger; Anxiety; Brain Injuries; Cognition; Cognit | 2006 |
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
Topics: Adult; Buprenorphine; Cognition; Cognition Disorders; Drug Therapy, Combination; Female; Humans; Mal | 2007 |
[Long-term treatment with opioids and cognition disorders].
Topics: Analgesics, Opioid; Cognition Disorders; Humans; Methadone; Narcotics; Opioid-Related Disorders; Tim | 1994 |
Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users.
Topics: Adult; Analysis of Variance; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cognition Disorders; | 1994 |
Magnetic resonance abnormalities in HIV infection: a study in the drug-user risk group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Brain; Brain Diseases; Cognition D | 1993 |
[Melatonin, methadone, tacrine, vitamin K antagonists and low-molecular-weight heparin].
Topics: Aged; Anticoagulants; Cholinesterase Inhibitors; Circadian Rhythm; Cognition Disorders; Heroin Depen | 1996 |
Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment.
Topics: Adult; Ambulatory Care; Attention; Attention Deficit Disorder with Hyperactivity; Clonidine; Cogniti | 1999 |
Cognitive impairment among methadone maintenance patients.
Topics: Adult; Aged; Alcoholism; Case-Control Studies; Cognition Disorders; Craniocerebral Trauma; Drug Over | 2000 |
Cognitive impairment in methadone maintenance patients.
Topics: Adult; Cocaine; Cocaine-Related Disorders; Cognition Disorders; Concept Formation; Female; Heroin; H | 2002 |
Neuropsychological deficits and opiate abuse.
Topics: Adult; Cognition Disorders; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Narcoti | 2002 |
Personality characteristics in a sample of heroin addict methadone maintenance applicants.
Topics: Adult; Affective Symptoms; Arizona; Cognition Disorders; Female; Heroin Dependence; Humans; Male; Me | 1976 |
A prospective longitudinal study of neuropsychological and psychosocial factors in asymptomatic individuals at risk for HTLV-III/LAV infection in a methadone program: preliminary findings.
Topics: Acquired Immunodeficiency Syndrome; Cognition Disorders; Heroin Dependence; Humans; Longitudinal Stu | 1987 |